Pharma Journalist -

Maxor National Pharmacy Services announced that Vertex Pharmaceuticals has now included Maxor Specialty in its specialty pharmacy network with immediate effects. Patients may now…
Read More...

Center for Drug Evaluation under China FDA announced that rice-extracted human blood protein is "safe and effective," and its quality can be easily controlled. The Chinese FDA has also…
Read More...

Albireo Pharma announced that USPTO (United States Patent and Trademark Office) has allowed U.S. Patent Application No. 15/276,446, “IBAT inhibitors for the treatment of liver diseases”…
Read More...

Avenue Therapeutics announced that it has received Notice of Allowance from USPTO (U.S. Patent and Trademark Office) for a new patent application (U.S. Application No. 15/163,111),…
Read More...

Greater Than One (GTO) has appointed Kieran Walsh as President of its US operations with immediate effects. Walsh will be responsible for leading the GTO staff and offices in New York…
Read More...

MSD President, Jannie Oosthuizen and Astellas Pharma President and CEO, Yoshihiko Hatanaka together announced that MSD has submitted an application for marketing approval of a…
Read More...

Acasti Pharma announced that it has received an invitation to present the CaPre (omega-3 phospholipid) study results at the National Lipid Association Scientific Sessions in…
Read More...

XOMA Corporation announced it has earned a $10 million milestone payment as one Company asset licensed to one of its pharmaceutical partners advances into clinical development. XOMA…
Read More...

Jubilant Life Sciences Ltd, announced that Jubilant Pharma Limited, a material wholly owned subsidiary of the Company, has received Abbreviated New Drug Application (ANDA)  final …
Read More...

The U.S. FDA has expanded approved use of Vertex Pharmaceuticals manufactured Kalydeco (ivacaftor) for treating cystic fibrosis. The approval triples the number of rare gene mutations…
Read More...